![Heterogeneous CD3 Expression Levels in Differing T Cell Subsets Correlate with the In Vivo Anti-CD3–Mediated T Cell Modulation | The Journal of Immunology Heterogeneous CD3 Expression Levels in Differing T Cell Subsets Correlate with the In Vivo Anti-CD3–Mediated T Cell Modulation | The Journal of Immunology](https://www.jimmunol.org/content/jimmunol/194/5/2117/F4.large.jpg)
Heterogeneous CD3 Expression Levels in Differing T Cell Subsets Correlate with the In Vivo Anti-CD3–Mediated T Cell Modulation | The Journal of Immunology
![No cell is an island: circulating T cell:monocyte complexes are markers of immune perturbations | bioRxiv No cell is an island: circulating T cell:monocyte complexes are markers of immune perturbations | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2018/09/07/411553/F2.large.jpg)
No cell is an island: circulating T cell:monocyte complexes are markers of immune perturbations | bioRxiv
![Epredia™ Lab Vision™ CD3 (Early T-Cell Marker) Rabbit Monoclonal Antibody,: Primary Antibodies - Alphabetical Primary Antibodies | Fisher Scientific Epredia™ Lab Vision™ CD3 (Early T-Cell Marker) Rabbit Monoclonal Antibody,: Primary Antibodies - Alphabetical Primary Antibodies | Fisher Scientific](https://assets.fishersci.com/TFS-Assets/APD/product-images/F39696~p.eps-650.jpg)
Epredia™ Lab Vision™ CD3 (Early T-Cell Marker) Rabbit Monoclonal Antibody,: Primary Antibodies - Alphabetical Primary Antibodies | Fisher Scientific
![Natural Killer NK Cell Marker (CD3, NCAM1, CD94, NKG2D, SLAMF6, NK-p44) Antibody Panel - Human (ab254014) Natural Killer NK Cell Marker (CD3, NCAM1, CD94, NKG2D, SLAMF6, NK-p44) Antibody Panel - Human (ab254014)](https://www.abcam.com/ps/products/254/ab254014/Images/ab254014-344807-natural-killer-nk-cell-marker-antibody-panel-immunocytochemistry-immunofluorescence-ramos.jpg)
Natural Killer NK Cell Marker (CD3, NCAM1, CD94, NKG2D, SLAMF6, NK-p44) Antibody Panel - Human (ab254014)
PLOS ONE: FOXP3 Expression Is Upregulated in CD4+T Cells in Progressive HIV-1 Infection and Is a Marker of Disease Severity
![Frontiers | Low Double-Negative CD3+CD4−CD8− T Cells Are Associated with Incomplete Restoration of CD4+ T Cells and Higher Immune Activation in HIV-1 Immunological Non-Responders | Immunology Frontiers | Low Double-Negative CD3+CD4−CD8− T Cells Are Associated with Incomplete Restoration of CD4+ T Cells and Higher Immune Activation in HIV-1 Immunological Non-Responders | Immunology](https://www.frontiersin.org/files/Articles/224970/fimmu-07-00579-HTML/image_m/fimmu-07-00579-g001.jpg)
Frontiers | Low Double-Negative CD3+CD4−CD8− T Cells Are Associated with Incomplete Restoration of CD4+ T Cells and Higher Immune Activation in HIV-1 Immunological Non-Responders | Immunology
![Cells | Free Full-Text | Anti-CD3 Antibody Treatment Reduces Scar Formation in a Rat Model of Myocardial Infarction | HTML Cells | Free Full-Text | Anti-CD3 Antibody Treatment Reduces Scar Formation in a Rat Model of Myocardial Infarction | HTML](https://www.mdpi.com/cells/cells-09-00295/article_deploy/html/images/cells-09-00295-g005.png)
Cells | Free Full-Text | Anti-CD3 Antibody Treatment Reduces Scar Formation in a Rat Model of Myocardial Infarction | HTML
![NKT Cells in Mice Originate from Cytoplasmic CD3-Positive, CD4 − CD8 − Double-Negative Thymocytes that Express CD44 and IL-7Rα | Scientific Reports NKT Cells in Mice Originate from Cytoplasmic CD3-Positive, CD4 − CD8 − Double-Negative Thymocytes that Express CD44 and IL-7Rα | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-37811-0/MediaObjects/41598_2018_37811_Fig1_HTML.png)
NKT Cells in Mice Originate from Cytoplasmic CD3-Positive, CD4 − CD8 − Double-Negative Thymocytes that Express CD44 and IL-7Rα | Scientific Reports
![Different lymphocyte markers and cytokine expression in peripheral blood mononuclear cells in children with acute atopic dermatitis* | Allergologia et Immunopathologia Different lymphocyte markers and cytokine expression in peripheral blood mononuclear cells in children with acute atopic dermatitis* | Allergologia et Immunopathologia](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/13066301:105v32n05-13066301tab01.gif?idApp=UINPBA00004N)